Tag: Diabetes: Misc.
June 2017 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for June 2017. This roundup includes...
Tryptophan May Be Marker for Diabetic Nephropathy
Lower level of tryptophan, especially below 44.20 µM related to rapid decline in eGFR
Empagliflozin Ups β Cell Function in Impaired Fasting Glucose
Empagliflozin produces comparable glucosuria in subjects with impaired, normal fasting glucose
Estimated Prevalence of Diabetes 10.9 Percent in China
Overall, 36.5 percent of those with diabetes were aware of their diabetes, 32.2 percent were treated
Risk of Cardiovascular Events Similar With, Without Diabetes
Patients with versus without diabetes, without CAD, were more often treated with statins and aspirin
Good Results for Zone MPC-Based Artificial Pancreas
Improved glycemic control for AP system versus sensor-augmented pump therapy
American Diabetes Association, June 9-13
The American Diabetes Association's 77th Scientific Sessions The annual meeting of the American Diabetes Association was held from June 9 to 13 in...
SGLT2 Inhibitors Linked to Increased Risk of Ketoacidosis
Associated with approximately twice the risk of DKA compared to DPP4 inhibitors
Severe Hypoglycemia Rates Have Equilibrated for DCCT Groups
Preceding episode of severe hypoglycemia deemed most powerful predictor of subsequent episodes
Hypothalamic Lin28a Shows Role in Glucose Homeostasis
Hypothalamic ventromedial Lin28a enhances glucose metabolism in diet-induced obesity in mice
